Southern Fox Investments Ltd has disclosed a 27.50% interest in Allergy Therapeutics plc, representing 1,307,377,398 ordinary shares. The disclosure was made in accordance with Rule 8.3 of the Takeover Code. The form also states that Southern Fox Investments Ltd holds 16,666,666 warrants at an exercise price of 30 pence, with an expiry date of 28 February 2028. The form does not indicate any recent purchases or sales of the company's securities. No indemnity or option arrangements, agreements, or understandings relating to options or derivatives were disclosed. No supplemental form or attachments were included in the disclosure. The contact person for the disclosure is Anthony Parker, with a telephone number of +441179742561.